Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
International trial of relapse treatment in childhood standard-risk acute lymphoblastic leukemia
MOH_2017-08-09_000706Phase 3Recruiting
- Sponsor
- ד"ר רונית אלחסיד
- Start
- Apr 2014
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of epratuzumab in acute lymphoblastic leukemia (ALL) (4 arms), sponsored by ד"ר רונית אלחסיד. Started Apr 2014; status: recruiting.
02
Drugs
epratuzumab
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on MOH_2017-08-09_000706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-08-09_000706.